NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
30.40
+0.14 (0.46%)
At close: Jun 12, 2026, 4:00 PM EDT
31.00
+0.60 (1.97%)
After-hours: Jun 12, 2026, 7:38 PM EDT

NAMS Stock Forecast

Stock Price Forecast

According to 14 analysts polled by S&P Global, NAMS stock has a consensus rating of "Strong Buy" and an average price target of $49.69. The average 1-year stock price forecast is 63.45% higher than the current stock price, while the lowest is $37.18 (+22.30%) and the highest is $58.94 (+93.88%).

Price Target: $49.69 (+63.45%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$37.18$49.69$49.9$58.94
Change+22.30%+63.45%+64.14%+93.88%
* Price targets were last updated on May 12, 2026.

Analyst Ratings

The average analyst rating for NAMS stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy101011111010
Buy333333
Hold111111
Sell000000
Strong Sell000000
Total141415151414

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Piper Sandler
Piper Sandler
Buy
Maintains
$60
BuyMaintains$60+97.37%May 12, 2026
Truist Financial
Truist Financial
Buy
Maintains
n/a
BuyMaintainsn/an/aMay 8, 2026
Guggenheim
Guggenheim
Buy
Maintains
$45
BuyMaintains$45+48.03%May 8, 2026
Needham
Needham
Buy
Maintains
$48
BuyMaintains$48+57.89%May 7, 2026
TD Cowen
TD Cowen
Buy
Maintains
n/a
BuyMaintainsn/an/aMay 7, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
27.56M
from 22.50M
Increased by 22.48%
Revenue Next Year
156.00M
from 27.56M
Increased by 466.01%
EPS This Year
-1.87
from -1.72
EPS Next Year
-1.31
from -1.87
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
-102.69M14.09M45.56M22.50M27.56M
Revenue Growth
---86.28%223.37%-50.61%22.48%
Gross Profit
-102.69M14.09M45.56M22.50M27.56M
Gross Margin
-100.00%100.00%100.00%100.00%100.00%
Operating Income
-34.98M-3.56M-182.97M-176.29M-225.68M-247.51M
Net Income
-41.79M-22.63M-176.94M-241.60M-203.82M-225.32M
EPS
-----1.72-1.87
Free Cash Flow
-15.94M22.70M-72.00M-43.17M-112.91M-160.27M
No. Analysts
-----15
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High43.2M
Avg27.6M
Low3.0M

Revenue Growth

Revenue Growth202620272028
High
92.2%
Avg
22.5%
Low
-86.6%

EPS Forecast

EPS202620272028
High-
Avg-1.87
Low-

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-